CHAPTER 21 – ANTIBODIES TO TUMOR-ASSOCIATED GANGLIOSIDES (GM2 AND GD2): POTENTIAL FOR SUPPRESSION OF MELANOMA RECURRENCE

[1]  J. Paulson,et al.  Ganglioside GM2 as a human tumor antigen (OFA-I-1). , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[2]  J. Paulson,et al.  Identification of a human neuroectodermal tumor antigen (OFA-I-2) as ganglioside GD2. , 1982, Proceedings of the National Academy of Sciences of the United States of America.

[3]  R. Saxton,et al.  Human antibody to OFA-I, a tumor antigen, produced in vitro by Epstein-Barr virus-transformed human B-lymphoid cell lines. , 1982, Proceedings of the National Academy of Sciences of the United States of America.

[4]  F. Kourilsky,et al.  Induction of antibody-producing cell lines by Epstein-Barr virus. , 1982, Pathologie-biologie.

[5]  R. Warnke,et al.  Treatment of B-cell lymphoma with monoclonal anti-idiotype antibody. , 1982, The New England journal of medicine.

[6]  R. Yu,et al.  Gangliosides: structure, isolation, and analysis. , 1982, Methods in enzymology.

[7]  D. Morton,et al.  Cleaner air in Volgograd. , 1994, Environmental health perspectives.

[8]  L. Svennerholm,et al.  A procedure for the quantitative isolation of brain gangliosides. , 1980, Biochimica et biophysica acta.

[9]  D. Morton,et al.  Oncofoetal antigen I: a target for immune cytolysis of human cancer. , 1979, British Journal of Cancer.

[10]  R. Saxton,et al.  Establishment of paired tumor cells and autologous virus‐transformed cell lines to define humoral immune responses in melanoma and sarcoma patients , 1978, International journal of cancer.

[11]  G. Klein,et al.  EB virus-induced B lymphocyte cell lines producing specific antibody , 1977, Nature.

[12]  K. Irie,et al.  A membrane antigen common to human cancer and fetal brain tissues. , 1976, Cancer research.

[13]  L. Staniland,et al.  ‘Solubilized’ Chemicals for the Control of Plant Nematodes , 1952, Nature.